Atlas Trials

Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390

Clinical trial NCT00996216 · COMPLETED

Trial details

NCT number
NCT00996216
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C
Start date
2009-09-01
Primary completion
2013-02-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.